World Health Organization clashes with DEA on marijuana compound CBD

The US Drug Enforcement Administration has long held that the non-psychoactive component of marijuana, cannabidiol, is a schedule I drug. That is, a drug that has no accepted medical use and a high potential for abuse. But according to a preliminary report embraced by the World Health Organization this week, the DEA’s long-held stance is tripping.
Read more: https://arstechnica.com/science/2017/12/who-report-data-on-marijuana-compound-does-not-justify-dea-scheduling/?source=Snapzu